Whether it's to test a vaccine or a microbicide to reduce HIV risk, clinical trials rely heavily on the goodwill of people. Without them, such trials won't take place. But what motivates people to want to be part of these trials?
South Africa is sitting on a 'future time bomb' as employers remove medical health insurance from employees when they retire.
The recent announcement about the failure of the leading AIDS vaccine candidate developed by Merck & Co. is another in a series of disappointing setbacks in HIV prevention. How we as a global community choose to respond to this news, however, is the real test.
A new organisation supported by US celebrities has caused controversy in northern KwaZulu-Natal, prompting the question: is there enough co-ordination of donor funding of HIV/AIDS?
Good news is hard to come by in rural Eastern Cape, but Madwaleni Hospital's HIV programme is inspiring.
Government has committed itself to announcing a new protocol for the prevention of mother to child transmission (PMTCT) programme within the next two weeks.
For weeks, only three people turned up for support group meetings in Nkanya but Kopana and her colleagues didn't give up.
Without a lift to the hospital, Faniswa Methi probably wouldn't have made it.
When scientists first started developing vaccines against HIV, they believed that it would take them 10 years to find one. Now, more than two decades later, they say they don't know how long it will take.
In a few week's time, results of a major Phase 3 microbicide trial will be released and the women who took part can't wait for the results
Big pharmaceutical companies need to change the way they work to reach 85% of the world's consumers who don't have proper access to medicine.
Results from the first ever microbocide trial to go through all phases of research are due to be released early next year. A microbicide is a substance that can be inserted vaginally or anally with the aim of protecting its users from HIV infection.
It's a scandal that tuberculosis has not been given proper attention and this is mainly because it is a disease of the poor, said Nils Billo, Executive Director of the International Union Against Tuberculosis (TB) and Lung Disease (The Union).
It's a scandal that tuberculosis has not been given proper attention and this is mainly because it is a disease of the poor, said Nils Billo, Executive Director of the International Union Against Tuberculosis (TB) and Lung Disease (The Union).
As the international community is focusing on HIV/AIDS, malaria and tuberculosis another rapidly growing epidemic, diabetes, is also demanding attention.
Be in the know with our free weekly newsletter. We deliver a round-up of our top stories and insightful reads from across the web.